Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15,610 | $11,160 | $79 | $106 |
| Dep. & Amort. | $4,615 | $4,254 | $31 | $31 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$727 | -$9,296 | -$41 | $1 |
| Other Non-Cash | -$12,977 | -$7,795 | -$6,748 | $1,395 |
| Operating Cash Flow | $6,521 | -$1,677 | -$50 | $13 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,507 | -$1,201 | -$54 | -$47 |
| Net Acquisitions | $0 | $0 | $1 | $0 |
| Inv. Purchases | -$978 | -$2,400 | -$8 | -$47 |
| Inv. Sales/Matur. | $14,160 | $11,902 | $106 | $182 |
| Other Inv. Act. | -$3,723 | $389 | $5,957 | $10,688 |
| Investing Cash Flow | $4,952 | $8,690 | $6,001 | $10,776 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60 | -$150 | -$150 | -$103 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$5,293 | -$6,000 | $0 | $0 |
| Dividends Paid | -$3,801 | -$3,722 | -$3,135 | -$2,536 |
| Other Fin. Act. | -$171 | -$134 | -$135 | -$117 |
| Financing Cash Flow | -$9,325 | -$10,006 | -$3,420 | -$2,756 |
| Forex Effect | $27 | -$3 | -$21 | $4 |
| Net Chg. in Cash | $2,271 | -$2,997 | $121 | $9,557 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45,887 | $48,884 | $247 | $393 |
| End Cash | $48,158 | $45,887 | $368 | $247 |
| Free Cash Flow | $1,491 | -$3,510 | -$105 | -$34 |